MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • Patient Community Day at MSToronto2026
  • The ECTRIMS Podcast at MSToronto2026
  • Antiviral Reverses Disability in Mouse Model of MS
  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Panellists at Patient Community Day 2026, held at the conclusion of MSToronto2026, are shown in discussion on stage.

Patient Community Day at MSToronto2026

MStranslate
November 6, 2026
Community, ECTRIMS, Events, Research
The word Toronto is shown displayed in large lettering on the edge of what could be a town square in downtown Toronto.

The ECTRIMS Podcast at MSToronto2026

MStranslate
November 5, 2026
Conferences, ECTRIMS, Research
1 Comment
3D medical illustration of HIV virus cells.

Antiviral Reverses Disability in Mouse Model of MS

MStranslate
September 28, 2026
Research, Treatments
cognition

Assessing & Monitoring Cognition in MS

MStranslate
August 11, 2026
Cognition, Research
News

Potential Changes to MS Treatment Access in Australia

MStranslate
July 2, 2026
Treatments
remyelination

Latest Remyelination Research Developments in MS

MStranslate
November 24, 2021
Dr Travis Stiles, ECTRIMS, Remyelination, Research, Videos
In his first feature as an official member of the MStranslate team, Novoron Bioscience CEO, Dr Travis Stiles, recently sat down with our co-founder, Brett Drummond, to discuss the latest developments in...
ECTRIMS Congress 2021

ECTRIMS Congress 2021: Research Insights

MStranslate
October 18, 2021
Conferences, Dr Travis Stiles, ECTRIMS, Research, Videos
Due to the ongoing challenges and restrictions of the COVID-19 pandemic, ECTRIMS Congress 2021 was once again held as a virtual conference this year.  Taking place between October 13 and 15, this meeting...
Dr Travis Stiles

Dr Travis Stiles Officially Joins MStranslate

MStranslate
October 13, 2021
Collaboration, Community, Dr Travis Stiles
1 Comment
Many in our community will recognise Dr Travis Stiles (CEO, Novoron Bioscience), as he has been a regular guest contributor to MStranslate since 2016.  Now, we can excitedly share that Travis is joining the...
Multiple Sclerosis Cure

Community Q&A: Why Don’t We Have An MS Cure?

MStranslate
October 11, 2021
Community, Opinion, Q&A
In this video, our co-founder and chief science communicator, Brett Drummond, answers one of the recent questions submitted by a member of the MStranslate community. In this instance, he shares his opinions on...
COVID-19 vaccines

Community Q&A: COVID-19 Vaccines & MS

MStranslate
September 29, 2021
Community, COVID-19, Q&A, Research
1 Comment
In this video, our co-founder and chief science communicator, Brett Drummond, answers one of the recent questions submitted by a member of the MStranslate community. In this instance, it looks at the latest...
blood-brain barrier

Community Q&A: The Blood-Brain Barrier

MStranslate
September 23, 2021
Community, Q&A, Research
2 Comments
What is the blood-brain barrier? Why is the blood-brain barrier important in multiple sclerosis (MS)?  Is research being undertaken to repair the blood-brain barrier in people living with multiple sclerosis,...
cure

UPDATED: Redefining A “Cure” For Multiple Sclerosis

MStranslate
September 14, 2021
Opinion
5 Comments
UPDATED: SEPTEMBER 14, 2021 https://youtu.be/02TR0rhHGUc ORIGINAL ARTICLE: JUNE 19, 2018 The following is an opinion piece written by MStranslate co-founder, Brett Drummond.  As always, we value your...
lockdown fatigue

Not MS Fatigue, but Lockdown Fatigue: Dr Sally Shaw

MStranslate
August 13, 2021
COVID-19, Dr Sally Shaw, Infection, Mental Health, Symptoms
By Dr Sally Shaw. Lockdown is a strange beast isn’t it?  Whether you are flat out on Zoom, or staring at the ceiling between Netflix episodes, most people are reporting high levels of ‘over it’ and...
Constipation multiple sclerosis

Constipation & Multiple Sclerosis: Study Insights

MStranslate
August 5, 2021
Gut microbiome, Research
The gut microbiome is an area of significant interest in multiple sclerosis (MS) research. Studies have shown that people living with MS have different levels of diversity in their gut microbiome compared to...
fatigue

Treating Fatigue in Multiple Sclerosis

MStranslate
July 20, 2021
Fatigue, Research, Symptoms, Treatments
Fatigue.  It is one of the most commonly reported symptoms by people living with multiple sclerosis (MS).  Not only do many people experience it, but they also indicate that it is the symptom that has the...
  1. 2
  2. 3
  3. 4
  4. 5
  5. 6
  6. 7
  7. 8

Recent Posts

  • Patient Community Day at MSToronto2026
  • The ECTRIMS Podcast at MSToronto2026
  • Antiviral Reverses Disability in Mouse Model of MS
  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia

Recent Comments

  • Patient Community Day at MSToronto2026 on The ECTRIMS Podcast at MSToronto2026
  • MStranslate on Multiple Sclerosis Research In 2026
  • MStranslate on Multiple Sclerosis Research In 2026
  • K on Multiple Sclerosis Research In 2026
  • Mohammad on Multiple Sclerosis Research In 2026

Calendar

November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Sep    

Archives

Categories

Posts

  • Patient Community Day at MSToronto2026
  • The ECTRIMS Podcast at MSToronto2026
  • Antiviral Reverses Disability in Mouse Model of MS
  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.